Eisai
Jeffrey Darling, PhD, currently serves as a Medical Science Liaison at Eisai US, where the focus is on developing innovative solutions for diagnosing and treating Alzheimer's disease and other neurodegenerative disorders. Prior to this role, Jeffrey worked as a Medical Science Liaison at Life Molecular Imaging, contributing to advancements in molecular imaging for improved disease detection and therapeutic outcomes. Jeffrey's academic background includes a Doctor of Philosophy in Neuroscience from Tulane University, complemented by a Master of Science in Neuroscience and a Bachelor of Science in Neuroscience. Additionally, experience includes a postdoctoral fellowship at The University of Texas at Austin, doctoral research at Tulane University, and teaching roles at Jesuit High School of New Orleans.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.